Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 370

3.

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

[No authors listed]

Lancet. 1998 Sep 12;352(9131):854-65. Erratum in: Lancet 1998 Nov 7;352(9139):1558.

PMID:
9742977
[PubMed - indexed for MEDLINE]
4.
5.
6.

UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.

Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC.

Diabet Med. 1998 Apr;15(4):297-303.

PMID:
9585394
[PubMed - indexed for MEDLINE]
8.

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

DeFronzo RA, Goodman AM.

N Engl J Med. 1995 Aug 31;333(9):541-9.

PMID:
7623902
[PubMed - indexed for MEDLINE]
Free Article
10.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
11.

The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial.

Chiasson JL, Josse RG, Hunt JA, Palmason C, Rodger NW, Ross SA, Ryan EA, Tan MH, Wolever TM.

Ann Intern Med. 1994 Dec 15;121(12):928-35.

PMID:
7734015
[PubMed - indexed for MEDLINE]
12.
13.
14.

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

[No authors listed]

Diabetes. 1995 Nov;44(11):1249-58. Erratum in: Diabetes 1996 Nov;45(11):1655.

PMID:
7589820
[PubMed - indexed for MEDLINE]
15.
17.

Effects of basal insulin analog and metformin on glycaemia control and weight as risk factors for endothelial dysfunction.

Ascić-Buturović B, Kacila M.

Bosn J Basic Med Sci. 2008 Nov;8(4):309-12.

PMID:
19125700
[PubMed - indexed for MEDLINE]
18.

Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes.

Marena S, Tagliaferro V, Montegrosso G, Pagano A, Scaglione L, Pagano G.

Diabete Metab. 1994 Jan-Feb;20(1):15-9.

PMID:
8056129
[PubMed - indexed for MEDLINE]
19.

Latin-American trial of orlistat for weight loss and improvement in glycaemic profile in obese diabetic patients.

Halpern A, Mancini MC, Suplicy H, Zanella MT, Repetto G, Gross J, Jadzinsky M, Barranco J, Aschner P, Ramirez L, Matos AG.

Diabetes Obes Metab. 2003 May;5(3):180-8.

PMID:
12681025
[PubMed - indexed for MEDLINE]
20.

Efficacy of combined treatments in NIDDM patients with secondary failure to sulphonylureas. Is it predictable?

Trischitta V, Italia S, Raimondo M, Guardabasso V, Licciardello C, Runello F, Mazzarino S, Sangiorgi L, Anello M, Vigneri R.

J Endocrinol Invest. 1998 Dec;21(11):744-7.

PMID:
9972673
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk